Cart (0 Items)
Your cart is currently empty.
View ProductsSize | 100ug, 1MG |
---|---|
Isotype | FabG1 |
Brand | ProteoGenix |
Product type | Primary Antibodies |
Clonality | Monoclonal Antibody |
Expression system | Mammalian cells |
Applications | Elisa, WB |
Product name | Ranibizumab Biosimilar - Anti-VEGF mAb - Research Grade |
---|---|
Source | DrugBank DB01270 |
Species | Human |
Molecular weight | 48kDa |
Purity | >85% |
Buffer | PBS pH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Aliases /Synonyms | Ranibizumab,Ranibizumab,VEGF,anti-VEGF |
Reference | PX-TA1008 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | FabG1 |
Clonality | Monoclonal Antibody |
Ranibizumab is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the “wet” type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion. This product is for research use only.
Ranibizumab Biosimilar - Anti-VEGF mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Immobilized VEGFA / VEGF165, C-His, recombinant protein (cat. No. PX-P5977) at 0.5µg/mL (100µL/well) can bind Ranibizumab Biosimilar - Anti-VEGF mAb (cat. No. PX-TA1008) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 22.11M.
Related products
Send us a message from the form below
Your cart is currently empty.
View Products
Reviews
There are no reviews yet.